Google partner and GlaxoSmithKline to join $700 million forces

Two of the world’s biggest tech and drug companies are joining forces to found an entirely new company called Galvani Bioelectrics based on bioelectronics research.

GlaxoSmithKline and Verily Life Sciences (which is under the umbrella of Google’s parent company, Alphabet) are set to spend more than $725 million on the new venture. They’ll work in both originator companies’ hometowns of London and San Francisco.

Bioelectronic medicine focuses on manipulating the body’s electrical impulses for therapeutic ends, instead of chemical or physical mechanisms.

Check out Forbes to see more business-end details of the deal.